Used in pharmaceutical synthesis, particularly in the development of antifungal agents. It serves as a key intermediate in the production of tavaborole, a topical treatment for onychomycosis (fungal nail infection). The compound's boron-containing structure enables unique interactions with biological targets, enhancing its efficacy in inhibiting fungal protein synthesis. Its application is primarily limited to medicinal chemistry and drug manufacturing.